ALTS: ASCUS Cytology Review

ASCUS 3379 cases. On Review:

Concurred ASCUS 55%

Upgraded to LSIL 11%

Upgraded to HSIL 3% = 14% SIL

Downgraded to Negative 31%

Soloman D, et al, 2001 JNCI 93(4):293-99